NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
Publication
, Journal Article
Benson, AB; Venook, AP; Al-Hawary, MM; Cederquist, L; Chen, Y-J; Ciombor, KK; Cohen, S; Cooper, HS; Deming, D; Engstrom, PF; Garrido-Laguna, I ...
Published in: J Natl Compr Canc Netw
April 2018
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2018
Volume
16
Issue
4
Start / End Page
359 / 369
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Humans
- Colonic Neoplasms
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., … Freedman-Cass, D. A. (2018). NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw, 16(4), 359–369. https://doi.org/10.6004/jnccn.2018.0021
Benson, Al B., Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi-Jen Chen, Kristen K. Ciombor, Stacey Cohen, et al. “NCCN Guidelines Insights: Colon Cancer, Version 2.2018.” J Natl Compr Canc Netw 16, no. 4 (April 2018): 359–69. https://doi.org/10.6004/jnccn.2018.0021.
Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen Y-J, Ciombor KK, et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018 Apr;16(4):359–69.
Benson, Al B., et al. “NCCN Guidelines Insights: Colon Cancer, Version 2.2018.” J Natl Compr Canc Netw, vol. 16, no. 4, Apr. 2018, pp. 359–69. Pubmed, doi:10.6004/jnccn.2018.0021.
Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen Y-J, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Garrido-Laguna I, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018 Apr;16(4):359–369.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2018
Volume
16
Issue
4
Start / End Page
359 / 369
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Humans
- Colonic Neoplasms
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis